Full-Time
Posted on 12/12/2024
Develops drugs for muscle function disorders
$50 - $60Hourly
Senior
San Bruno, CA, USA
Hybrid/onsite position; candidate must be located in the Bay Area.
Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a range of drugs in clinical trials, including omecamtiv mecarbil and reldesemtiv, aimed at treating conditions like heart failure, hypertrophic cardiomyopathy, amyotrophic lateral sclerosis, and spinal muscular atrophy. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from debilitating muscle-related conditions.
Company Stage
IPO
Total Funding
$58.4M
Headquarters
South San Francisco, California
Founded
1998
Help us improve and share your feedback! Did you find this helpful?